Molecular and Cellular Biology News

Brinkley honored with highest scientific honor from the American Society for Cell BiologyMay 8, 2014
Baylor's Dr. William R. Brinkley named as one of the recipients of the E.B. Wilson Medal.
Enzyme presents drug target to rare lung disease Apr 1, 2014
Baylor researchers find an enzyme may provide a new way to attack lymphangioleiomyomatosis, a rare lung disease predominately affects women.
Maestro coregulator SRC-2 orchestrates metabolism and circadian rhythmFeb 13, 2014
Baylor researchers find steroid receptor coactivator-2, a master molecule, synchronizes whole-body metabolism with circadian rhythm.
High throughput “viewing” identifies new regulator of estrogen receptorJan 23, 2014
A high throughput microscopy technique enabled our researchers to identify a highly amplified gene in many tumors, including breast, prostate and ovarian cancer.
Disease gene finding solves international medical mysteryJan 23, 2014
Combined, international effort helps Baylor doctors identify woman's illness.
Excess bile acids can signal beginning of liver cancerNov 21, 2013
The road to liver cancer can start with the toxic and chronic pile-up of bile acids that act as tumor promoters.
Master molecule SRC-2 sets stage for embryo implantationOct 24, 2013
Baylor researchers find understanding how SRC-2 reprograms the endometrium to be receptive to implantation is a critical to developing methods to help women at high risk for early pregnancy loss.
Baylor receives $960,000 plus in Komen breast cancer grantsAug 1, 2013
Four Baylor College of Medicine researchers received new grant funding from Susan G. Komen for the Cure to help advance breast cancer research.
Loss of tumor suppressor SPOP releases cancer potential of SRC-3Apr 1, 2013
BCM researchers say SRC-3 could prove an important target for treatment of many cancers along with breast and prostate tumors.
$11.8 million contract funds microbiome work in type 1 diabetesJan 8, 2013
Three-year, 11.8 million contract with the NIH and University of South Florida will fund BCM research for type 1 diabetes microbiome work.